On point in primary CNS lymphoma.

Hematological Oncology
Mazie TsangJames Rubenstein

Abstract

Primary CNS lymphoma (PCNSL) is an aggressive brain tumor that represents a significant challenge both to elucidate its biological pathogenesis as well as to develop definitive precision medicines with minimal collateral toxicity. We highlight the key issues in diagnosis and treatment and focus on emerging technologies, current options among consolidation strategies, and biological agents. We anticipate that further development of molecular diagnostics and molecular imaging approaches that elucidate minimal residual disease in brain parenchyma, leptomeninges, intraocular compartments and even bone marrow will greatly impact the delivery and timing of cytotoxic and biological therapies. Implementation of these approaches is likely essential to clarify ongoing discrepancies in the interpretation of clinical trial results that currently are based on relatively unrefined definitions of response. While the results of early phase investigations involving ibrutinib and the IMiD agents, lenalidomide, pomalidomide, as well as avadomide, strongly support the hypothesis that the B-cell receptor (BCR) pathway, involving MYD88 and CD79B and NF-kB activation, is critical to the pathogenesis of PCNSL, much work is needed to elucidate mechanis...Continue Reading

References

Apr 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L M DeAngelisU Kher
Jul 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D R MacdonaldJ G Cairncross
Mar 21, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L E AbreyJ Yahalom
Oct 24, 2002·Blood·James L RubensteinMarc A Shuman
Dec 19, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lisa M DeAngelisUNKNOWN Radiation Therapy Oncology Group Study 93-10
Mar 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tracy BatchelorRegina Priet
Apr 12, 2003·Neuroimaging Clinics of North America·Terence Z WongR Edward Coleman
Jun 16, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lauren E AbreyUNKNOWN International Primary CNS Lymphoma Collaborative Group
Sep 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kristoph JahnkeEckhard Thiel
Feb 22, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James L RubensteinMarc Shuman
Jun 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leslie L MuldoonEdward A Neuwelt
Jun 9, 2007·British Journal of Haematology·M PonzoniUNKNOWN International Extranodal Lymphoma Study Group
Dec 7, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sushmita RoyJames L Rubenstein
Mar 12, 2008·The Journal of Experimental Medicine·David G BrooksMichael B A Oldstone
Dec 8, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alexander SunHak Choy
Dec 24, 2010·Nature·Vu N NgoLouis M Staudt
Apr 26, 2011·Clinical Radiology·Y Z TangT Wilhelm
Jan 10, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Matthew J WieduwiltJames L Rubenstein
Apr 11, 2013·Blood·James L RubensteinClifford Lowell
Nov 6, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Cigall KadochJames L Rubenstein
Sep 12, 2014·Molecular and Cellular Biochemistry·Dan HongGuo-Gang Zhang
Mar 3, 2015·Proceedings of the National Academy of Sciences of the United States of America·Idit Sagiv-BarfiRonald Levy
Mar 20, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ayako MasakiShinsuke Iida
Mar 16, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Agnieszka KorfelPhilipp Kiewe
May 30, 2017·Cancer Cell·Michail S LionakisWyndham H Wilson
Jun 18, 2017·Cancer Discovery·Christian GrommesIngo K Mellinghoff
Aug 24, 2017·The New England Journal of Medicine·Jeremy S AbramsonIsabel C Arrillaga-Romany
Dec 10, 2017·Hematology·James L Rubenstein
Mar 7, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Tilly VarugheseGil Redelman-Sidi

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Related Papers

Blood
Lauren R Schaff, Christian Grommes
Current Opinion in Oncology
Carole Soussain, Khê Hoang-Xuan
Best Practice & Research. Clinical Haematology
Andrés J M Ferreri, Emerenziana Marturano
© 2022 Meta ULC. All rights reserved